Inter Pharma PCL (IP.BK) Stock Price

Inter Pharma PCL Price

CLOSED
5.30THB-0.05 (-0.94 %)
Market closed

Revenue has compounded at 44.3% per year over the past 10 years to 2.19 B THB. Earnings per share have declined at 17.5% per year over the last 10 years. Inter Pharma PCL's net margin stands at 5.6%, down from 11.6% several years earlier. Inter Pharma PCL currently offers a dividend yield of about 0.40%. The payout ratio is around 57% of earnings. Analysts set a median price target of 10.04 THB, implying 89.5% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 69% above its 52-week low.

Inter Pharma PCL stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Inter Pharma PCL over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Inter Pharma PCL stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Inter Pharma PCL's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Inter Pharma PCL Stock Price History
DateInter Pharma PCL Price
7/31/20265.30 THB
7/30/20265.35 THB
7/29/20265.40 THB
7/28/20265.40 THB
7/27/20265.40 THB
7/24/20265.40 THB
7/23/20265.20 THB
7/22/20265.15 THB
7/21/20265.10 THB
7/20/20265.00 THB
7/17/20265.05 THB
7/16/20265.00 THB
7/15/20264.98 THB
7/14/20264.96 THB
7/13/20264.84 THB
7/10/20264.82 THB
7/9/20264.88 THB
7/8/20264.82 THB
7/7/20264.52 THB
7/6/20264.52 THB
7/3/20264.42 THB
7/2/20264.44 THB
7/1/20264.48 THB
6/30/20264.46 THB
6/29/20264.48 THB
6/26/20264.36 THB
6/25/20264.40 THB
6/24/20264.34 THB
6/23/20264.34 THB
6/22/20264.44 THB
6/19/20264.38 THB
6/18/20264.42 THB
6/17/20264.54 THB
6/16/20264.38 THB
6/15/20264.46 THB
6/12/20264.46 THB
6/11/20264.34 THB
6/10/20264.42 THB
6/9/20264.48 THB
6/8/20264.48 THB
6/5/20264.44 THB
6/4/20264.38 THB
6/3/20264.32 THB
6/2/20264.32 THB
6/1/20264.28 THB
5/29/20264.28 THB
5/28/20264.28 THB
5/27/20264.30 THB
5/26/20264.20 THB
5/25/20264.16 THB
5/22/20264.16 THB
5/21/20264.14 THB
5/20/20264.14 THB
5/19/20264.12 THB
5/18/20264.10 THB
5/15/20264.12 THB
5/14/20264.16 THB
5/13/20264.16 THB
5/12/20264.24 THB
5/11/20264.20 THB
5/8/20264.20 THB
5/7/20264.14 THB
5/6/20264.10 THB
5/5/20264.04 THB
5/4/20264.04 THB
5/1/20264.04 THB
4/30/20264.04 THB
4/29/20264.08 THB
4/28/20264.06 THB
4/27/20264.16 THB
4/24/20264.12 THB
4/23/20264.10 THB
4/22/20264.10 THB
4/21/20264.04 THB
4/20/20264.06 THB
4/17/20264.06 THB
4/16/20264.08 THB
4/10/20264.08 THB
4/9/20264.06 THB
4/8/20264.14 THB
4/7/20263.98 THB
4/3/20264.02 THB
4/2/20264.02 THB
4/1/20264.12 THB
3/31/20264.04 THB
3/30/20264.00 THB
3/27/20263.96 THB
3/26/20263.94 THB
3/25/20264.00 THB
3/24/20264.00 THB
3/23/20264.00 THB
3/20/20264.16 THB
3/19/20264.16 THB
3/18/20264.26 THB
3/17/20264.22 THB
3/16/20264.14 THB
3/13/20263.92 THB
3/12/20263.90 THB
3/11/20263.88 THB
3/10/20263.90 THB
3/9/20263.88 THB
3/6/20263.90 THB
3/5/20263.92 THB
2/26/20264.22 THB
2/25/20264.30 THB
2/24/20264.08 THB
2/23/20264.08 THB
2/20/20264.10 THB
2/19/20264.14 THB
2/18/20264.36 THB
2/17/20264.42 THB
2/16/20264.38 THB
2/13/20264.40 THB
2/12/20264.44 THB
2/11/20264.42 THB
2/10/20264.32 THB
2/9/20264.32 THB
2/6/20264.30 THB
2/5/20264.30 THB
2/4/20264.36 THB
2/3/20264.34 THB
2/2/20264.32 THB
1/30/20264.32 THB
1/29/20264.32 THB
1/28/20264.42 THB
1/27/20264.42 THB
1/26/20264.46 THB
1/23/20264.48 THB
1/22/20264.48 THB
1/21/20264.52 THB
1/20/20264.50 THB
1/19/20264.52 THB
1/16/20264.48 THB
1/15/20264.46 THB
1/14/20264.46 THB
1/13/20264.40 THB
1/12/20264.40 THB
1/9/20264.38 THB
1/8/20264.38 THB
1/7/20264.40 THB
1/6/20264.40 THB
1/5/20264.58 THB
12/30/20254.60 THB
12/29/20254.60 THB
12/26/20254.60 THB
12/25/20254.56 THB
12/24/20254.56 THB
12/23/20254.64 THB
12/22/20254.66 THB
12/19/20254.60 THB
12/18/20254.58 THB
12/17/20254.60 THB
12/16/20254.44 THB
12/15/20254.40 THB
12/12/20254.24 THB
12/11/20254.12 THB
12/9/20254.16 THB
12/8/20254.18 THB
12/4/20254.18 THB
12/3/20254.02 THB
12/2/20253.94 THB
12/1/20254.00 THB
11/28/20254.02 THB
11/27/20254.02 THB
11/26/20253.96 THB
11/25/20253.94 THB
11/24/20253.96 THB
11/21/20254.00 THB
11/20/20254.06 THB
11/19/20254.02 THB
11/18/20254.00 THB
11/17/20254.00 THB
11/14/20254.00 THB
11/13/20254.00 THB
11/12/20254.04 THB
11/11/20254.00 THB
11/10/20254.00 THB
11/7/20254.02 THB
11/6/20254.02 THB
11/5/20253.90 THB
11/4/20253.94 THB
11/3/20253.94 THB
10/31/20253.90 THB
10/30/20253.84 THB
10/29/20253.96 THB
10/28/20253.90 THB
10/27/20253.76 THB
10/24/20253.86 THB
10/22/20253.74 THB
10/21/20253.64 THB
10/20/20253.52 THB
10/17/20253.48 THB
10/16/20253.70 THB
10/15/20253.78 THB
10/14/20253.74 THB
10/10/20254.10 THB
10/9/20254.10 THB
10/8/20254.20 THB
10/7/20254.14 THB
10/6/20254.12 THB
10/3/20254.18 THB
10/2/20254.24 THB
10/1/20254.14 THB
9/30/20254.16 THB
9/29/20254.30 THB
9/26/20254.28 THB
9/25/20254.26 THB
9/24/20254.08 THB
9/23/20254.08 THB
9/22/20254.26 THB
9/19/20254.20 THB
9/18/20254.26 THB
9/17/20253.74 THB
9/16/20253.80 THB
9/15/20253.78 THB
9/12/20253.32 THB
9/11/20253.32 THB
9/10/20253.38 THB
9/9/20253.34 THB
9/8/20253.40 THB
9/5/20253.36 THB
9/4/20253.36 THB
9/3/20253.38 THB
9/2/20253.40 THB
9/1/20253.20 THB
8/29/20253.14 THB
8/28/20253.26 THB
8/27/20253.28 THB
8/26/20253.38 THB
8/25/20253.36 THB
8/22/20253.32 THB
8/21/20253.28 THB
8/20/20253.32 THB
8/19/20253.38 THB
8/18/20253.46 THB
8/15/20253.48 THB
8/14/20253.46 THB
8/13/20253.46 THB
8/8/20253.50 THB
8/7/20253.50 THB
8/6/20253.46 THB
8/5/20253.38 THB
8/4/20253.30 THB
Access this data via the Eulerpool API
Get Free API Key

Inter Pharma PCL Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
313.64 M THB
40.96 M THB
29.68 M THB
Jan 1, 2019
371.33 M THB
61.54 M THB
43.47 M THB
Jan 1, 2020
442.10 M THB
78.33 M THB
52.54 M THB
Jan 1, 2021
908.63 M THB
145.77 M THB
105.22 M THB
Jan 1, 2022
1.52 B THB
171.70 M THB
118.88 M THB
Jan 1, 2023
1.78 B THB
109.40 M THB
50.79 M THB
Jan 1, 2024
1.90 B THB
75.53 M THB
37.28 M THB
Jan 1, 2025
2.19 B THB
171.40 M THB
122.38 M THB

Inter Pharma PCL Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 1, 2026, 11:32 PM
 
REVENUEB THB
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM THB
EBITM THB
EBIT MARGIN%
NET INCOMEM THB
NET INCOME GROWTH%
DIV.THB
DIV. GROWTH%
SHARESM
20152016201720182019202020212022202320242025
0.060.130.250.310.370.440.911.521.781.902.19
–127.2797.6026.7218.5319.14105.4367.7316.946.5115.60
72.7368.8059.9260.0657.4158.8244.0540.5837.0037.4337.39
40.0086.00148.00188.00213.00260.00400.00618.00659.00710.00820.00
17.0027.0028.0040.0061.0078.00145.00171.00109.0075.00171.00
30.9121.6011.3412.7816.4417.6515.9711.236.123.957.80
13.0015.0015.0029.0043.0052.00105.00118.0050.0037.00122.00
–15.38–93.3348.2820.93101.9212.38-57.63-26.00229.73
–––––0.190.02–0.180.02–
––––––-88.89––-88.89–
10.00605.34605.34289.93288.40206.00298.01372.52372.52605.34605.34
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Inter Pharma PCL generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Inter Pharma PCL retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Inter Pharma PCL's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Inter Pharma PCL has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Inter Pharma PCL's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Inter Pharma PCL stock margins

The Inter Pharma PCL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inter Pharma PCL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inter Pharma PCL.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
60.13 %
13.06 %
9.46 %
Jan 1, 2019
57.61 %
16.57 %
11.71 %
Jan 1, 2020
59.01 %
17.72 %
11.88 %
Jan 1, 2021
44.11 %
16.04 %
11.58 %
Jan 1, 2022
40.60 %
11.27 %
7.80 %
Jan 1, 2023
37.02 %
6.14 %
2.85 %
Jan 1, 2024
37.42 %
3.98 %
1.96 %
Jan 1, 2025
37.41 %
7.81 %
5.58 %

Inter Pharma PCL Stock Revenue, EBIT, Earnings per Share

The Inter Pharma PCL earnings per share therefore indicates how much revenue Inter Pharma PCL has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
1.08 THB
0.14 THB
0.10 THB
Jan 1, 2019
1.29 THB
0.21 THB
0.15 THB
Jan 1, 2020
2.15 THB
0.38 THB
0.26 THB
Jan 1, 2021
3.05 THB
0.49 THB
0.35 THB
Jan 1, 2022
4.09 THB
0.46 THB
0.32 THB
Jan 1, 2023
4.78 THB
0.29 THB
0.14 THB
Jan 1, 2024
3.13 THB
0.12 THB
0.06 THB
Jan 1, 2025
3.62 THB
0.28 THB
0.20 THB

Inter Pharma PCL business model & stock analysis

Inter Pharma PCL Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Inter Pharma PCL historical P/E ratio, EBIT multiple, and P/S ratio

Inter Pharma PCL annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Inter Pharma PCL shares outstanding

The number of shares of Inter Pharma PCL was 605.34 M in 2025. This indicates how many shares Inter Pharma PCL is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
289.93 M Stocks
Jan 1, 2019
288.40 M Stocks
Jan 1, 2020
206.00 M Stocks
Jan 1, 2021
298.01 M Stocks
Jan 1, 2022
372.52 M Stocks
Jan 1, 2023
372.52 M Stocks
Jan 1, 2024
605.34 M Stocks
Jan 1, 2025
605.34 M Stocks

Inter Pharma PCL stock splits

In Inter Pharma PCL's history, there have been no stock splits.

Inter Pharma PCL Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20240.02THB↓ 88.1%1×
20230.18THB↑ 976.9%1×
20210.02THB↓ 91.0%1×
20200.19THB—1×

Inter Pharma PCL dividend payout ratio

In 2025, Inter Pharma PCL had a payout ratio of 61.69%. The payout ratio indicates the percentage of the company's profits that Inter Pharma PCL distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
47.28 %
Jan 1, 2019
47.28 %
Jan 1, 2020
31.72 %
Jan 1, 2021
4.06 %
Jan 1, 2022
47.28 %
Jan 1, 2023
81.27 %
Jan 1, 2024
56.51 %
Jan 1, 2025
61.69 %

Current Inter Pharma PCL forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
88.89 % (8)
Hold
11.11 % (1)
Sell
0.00 % (0)
12M Price Target
10.04
Last Price
5.30
Currency
THB
12M Return Potential
89.49 %
LTM Return
0 %

Inter Pharma PCL shareholder structure

% Name
31.99373%
Thanitnithiphan (Trinnawat)
Thanitnithiphan (Trinnawat)
20.01302%
Innobic LL Holding Co Ltd
Innobic LL Holding Co Ltd
2.74869%
Pattarakitkasem (Piriyarat)
Pattarakitkasem (Piriyarat)
2.12212%
Taypnimit (Wittayaa)
Taypnimit (Wittayaa)
1.29091%
Klinpratoom (Pavavit)
Klinpratoom (Pavavit)
1.28865%
Ekamornwong (Thamrongchai)
Ekamornwong (Thamrongchai)

Inter Pharma PCL Beneficial Ownership Filings (SEC 13D/G)

Free Float
31.8%
Float Shares
-
Shares Outstanding
-

Inter Pharma PCL Executives and Management Board

PK

Prof. Dr. Udom Kochinthorn

Independent Chairman of the Board

SC

Dr. Songsawut Sak Chalathorn

Chief Executive Officer, Director

SP

Ms. Supaporn Phithakpanit

Vice President - Accounting and Finance, Director

NA

Mrs. Naphon Dej Akkarat

Operations Director, Director

TT

Mrs. Thanatphan Thianthipsiri

Director of Management

Frequently asked questions about Inter Pharma PCL

Analysts currently set an average price target of 10.04 THB for the Inter Pharma PCL stock (median: 10.04 THB), implying +89.5 % versus the latest price. The consensus is based on 9 analyst ratings.

Inter Pharma PCL Analyst Price Targets 2026

All fundamentals and in-depth analysis of Inter Pharma PCL

Our stock analysis for Inter Pharma PCL stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inter Pharma PCL. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Inter Pharma PCL Stock
Inter Pharma PCL Revenue→
Inter Pharma PCL Stock
Inter Pharma PCL Net Income→
Inter Pharma PCL Stock
Inter Pharma PCL P/E→
Inter Pharma PCL Stock
Inter Pharma PCL P/S→
Inter Pharma PCL Stock
Inter Pharma PCL EBIT→
Inter Pharma PCL Stock
Inter Pharma PCL Dividend→
Inter Pharma PCL Stock
Inter Pharma PCL Directors Dealings→
Inter Pharma PCL Stock
Inter Pharma PCL Stocks→
Inter Pharma PCL Stock
Inter Pharma PCL Market capitalization→
Inter Pharma PCL Stock
Inter Pharma PCL Debt→
Inter Pharma PCL Stock
Inter Pharma PCL Liabilities→
Inter Pharma PCL Stock
Inter Pharma PCL Equity→
Inter Pharma PCL Stock
Inter Pharma PCL AAQS→
Inter Pharma PCL Stock
Inter Pharma PCL Employees→
Inter Pharma PCL Stock
Inter Pharma PCL ROE→
Inter Pharma PCL Stock
Inter Pharma PCL ROA→
Inter Pharma PCL Stock
Inter Pharma PCL ROCE→
Inter Pharma PCL Stock
Inter Pharma PCL News→
Inter Pharma PCL Stock
Inter Pharma PCL Analyst Price Targets→

Non-cyclical consumption Stocks

Intercos SpAIntegrated BiopharmaInternational BreweriesInsanInternational Co for Agricultural Corps SAEInnovative Food HoldingsInterparfumsInnovation New Material Technology CoInterparfumsInnovation Beverage GroupInti Agri Resources Tbk PTInnoGene CoAll Stocks A–Z →